Hainan Honz Pharmaceutical Co (300086) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.009x

Based on the latest financial reports, Hainan Honz Pharmaceutical Co (300086) has a cash flow conversion efficiency ratio of -0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-9.17 Million ≈ $-1.34 Million USD) by net assets (CN¥1.07 Billion ≈ $157.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300086 stock market capitalisation for the company's overall valuation and market capitalisation.

Hainan Honz Pharmaceutical Co - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Hainan Honz Pharmaceutical Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hainan Honz Pharmaceutical Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hainan Honz Pharmaceutical Co ranked by their cash flow conversion efficiency. Explore cash flow quality index of Hainan Honz Pharmaceutical Co to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
BRBI BR Partners S.A. ADSs
NASDAQ:BRBI
0.136x
Shenzhen Hifuture Electric
SHE:002168
-0.484x
China BlueChemical Ltd
F:H1Q
0.009x
Zhejiang Tongli Transmission Technology Co. Ltd. A
SHE:301255
N/A
Beijing LabTech Instruments Co Ltd
SHG:688056
0.014x
Zhejiang Heda Technology Co Ltd
SHG:688296
-0.012x
Benz Mining Corp
F:1VU
-0.404x
Nepes Corporation
KQ:033640
0.041x

Annual Cash Flow Conversion Efficiency for Hainan Honz Pharmaceutical Co (2007–2025)

The table below shows the annual cash flow conversion efficiency of Hainan Honz Pharmaceutical Co from 2007 to 2025. View 300086 stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥921.22 Million
≈ $134.80 Million
CN¥121.24 Million
≈ $17.74 Million
0.132x +114.62%
2024-12-31 CN¥1.17 Billion
≈ $170.52 Million
CN¥71.46 Million
≈ $10.46 Million
0.061x +19.53%
2023-12-31 CN¥1.38 Billion
≈ $201.65 Million
CN¥70.69 Million
≈ $10.34 Million
0.051x +137.15%
2022-12-31 CN¥1.36 Billion
≈ $198.35 Million
CN¥29.32 Million
≈ $4.29 Million
0.022x +196.65%
2021-12-31 CN¥1.55 Billion
≈ $227.35 Million
CN¥11.33 Million
≈ $1.66 Million
0.007x +169.76%
2020-12-31 CN¥1.60 Billion
≈ $234.39 Million
CN¥-16.74 Million
≈ $-2.45 Million
-0.010x -137.16%
2019-12-31 CN¥1.60 Billion
≈ $234.40 Million
CN¥45.06 Million
≈ $6.59 Million
0.028x -70.50%
2018-12-31 CN¥1.65 Billion
≈ $241.97 Million
CN¥157.66 Million
≈ $23.07 Million
0.095x +907.72%
2017-12-31 CN¥1.92 Billion
≈ $281.05 Million
CN¥18.17 Million
≈ $2.66 Million
0.009x -80.51%
2016-12-31 CN¥1.87 Billion
≈ $274.03 Million
CN¥90.88 Million
≈ $13.30 Million
0.049x +14.15%
2015-12-31 CN¥1.84 Billion
≈ $269.49 Million
CN¥78.30 Million
≈ $11.46 Million
0.043x +3.78%
2014-12-31 CN¥1.80 Billion
≈ $264.07 Million
CN¥73.93 Million
≈ $10.82 Million
0.041x -6.05%
2013-12-31 CN¥1.81 Billion
≈ $264.88 Million
CN¥78.93 Million
≈ $11.55 Million
0.044x -25.37%
2012-12-31 CN¥1.87 Billion
≈ $274.16 Million
CN¥109.46 Million
≈ $16.02 Million
0.058x +207.30%
2011-12-31 CN¥1.85 Billion
≈ $271.29 Million
CN¥-100.94 Million
≈ $-14.77 Million
-0.054x -224.62%
2010-12-31 CN¥1.83 Billion
≈ $267.58 Million
CN¥79.89 Million
≈ $11.69 Million
0.044x -88.77%
2009-12-31 CN¥240.49 Million
≈ $35.19 Million
CN¥93.58 Million
≈ $13.69 Million
0.389x -6.52%
2008-12-31 CN¥150.41 Million
≈ $22.01 Million
CN¥62.61 Million
≈ $9.16 Million
0.416x +57.69%
2007-12-31 CN¥115.89 Million
≈ $16.96 Million
CN¥30.59 Million
≈ $4.48 Million
0.264x --

About Hainan Honz Pharmaceutical Co

SHE:300086 China Drug Manufacturers - Specialty & Generic
Market Cap
$417.58 Million
CN¥2.85 Billion CNY
Market Cap Rank
#13294 Global
#3964 in China
Share Price
CN¥6.27
Change (1 day)
+0.16%
52-Week Range
CN¥5.63 - CN¥13.71
All Time High
CN¥17.75
About

Honz Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pediatric medicines in China and internationally. It operates through Pharmaceutical Manufacturing and Sales; and Daily Necessities Manufacturing and Sales segments. The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal, cough … Read more